—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Belite Bio Inc ADR (BLTE) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 27 out of 100 (momentum 49 · quality 7 · valuation 9), as of 2026-11-04.
  • Signal: Mixed moving-average stack — Trades -5.6% vs the 50-day and -5.1% vs the 200-day average, 23.9% below the 52-week high and +49.2% off the 52-week low; a golden cross printed 42 sessions ago. Computed from daily closes. (as of 2026-11-03)
  • Trend: Belite Bio Inc ADR trades 5.6% below its 50-day and 5.1% below its 200-day moving average. (as of 2026-11-03)

Belite Bio is a clinical-stage biopharmaceutical company that develops treatments for diseases with few existing options. Its main candidate, an orally administered drug called Tinlarebant, is in a phase 3 trial meant to protect retinal tissue in patients with Stargardt disease type 1 and geographic atrophy.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BLTE overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Mixed moving-average stack

Trades -5.6% vs the 50-day and -5.1% vs the 200-day average, 23.9% below the 52-week high and +49.2% off the 52-week low; a golden cross printed 42 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the BLTE chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on BLTE?

Mixed moving-average stack — Trades -5.6% vs the 50-day and -5.1% vs the 200-day average, 23.9% below the 52-week high and +49.2% off the 52-week low; a golden cross printed 42 sessions ago. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BLTE above its 50-day and 200-day moving averages?

As of 2026-11-03, Belite Bio Inc ADR trades -5.6% below its 50-day and -5.1% below its 200-day average, with the 20-day +0.7% away.

How far is BLTE from its 52-week high?

23.9% below the 52-week high and 49.2% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.